Cerner (CERN) Earning Favorable Media Coverage, Report Shows

News headlines about Cerner (NASDAQ:CERN) have trended positive on Saturday, Alpha One reports. Alpha One, a subsidiary of Accern, ranks the sentiment of press coverage by analyzing more than twenty million news and blog sources in real time. Alpha One ranks coverage of companies on a scale of -1 to 1, with scores closest to one being the most favorable. Cerner earned a news impact score of 0.29 on Alpha One’s scale. Alpha One also assigned news stories about the company an impact score of 80 out of 100, indicating that recent press coverage is likely to have an effect on the company’s share price in the next several days.

Here are some of the news stories that may have impacted Alpha One’s analysis:

Cerner (NASDAQ:CERN) opened at 64.10 on Friday. The firm’s 50-day moving average is $61.61 and its 200-day moving average is $54.55. Cerner has a 52 week low of $47.01 and a 52 week high of $67.50. The firm has a market cap of $21.18 billion, a price-to-earnings ratio of 33.04 and a beta of 1.05.

Cerner (NASDAQ:CERN) last announced its quarterly earnings data on Thursday, April 27th. The company reported $0.59 earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of $0.53 by $0.06. Cerner had a return on equity of 18.16% and a net margin of 13.27%. The firm had revenue of $1.26 billion for the quarter, compared to analysts’ expectations of $1.23 billion. During the same period last year, the business posted $0.53 earnings per share. The firm’s revenue for the quarter was up 10.7% on a year-over-year basis. On average, equities analysts anticipate that Cerner will post $2.51 earnings per share for the current year.

Several brokerages recently commented on CERN. Oppenheimer Holdings Inc. reiterated a “market perform” rating on shares of Cerner in a report on Friday, February 10th. Cantor Fitzgerald reiterated a “buy” rating and set a $66.00 price target on shares of Cerner in a report on Friday, February 10th. Jefferies Group LLC set a $74.00 target price on shares of Cerner and gave the stock a “buy” rating in a research note on Sunday, April 30th. Bank of America Corp upgraded shares of Cerner from an “underperform” rating to a “neutral” rating and upped their target price for the stock from $64.36 to $66.00 in a research note on Monday, May 15th. Finally, Zacks Investment Research downgraded shares of Cerner from a “hold” rating to a “sell” rating in a research note on Monday, April 3rd. One analyst has rated the stock with a sell rating, fifteen have given a hold rating and nine have issued a buy rating to the stock. The company currently has an average rating of “Hold” and an average target price of $64.33.

WARNING: “Cerner (CERN) Earning Favorable Media Coverage, Report Shows” was published by Transcript Daily and is the sole property of of Transcript Daily. If you are reading this piece on another website, it was illegally stolen and reposted in violation of United States and international copyright laws. The original version of this piece can be accessed at

In other Cerner news, VP Michael R. Battaglioli sold 4,000 shares of the firm’s stock in a transaction on Monday, May 1st. The stock was sold at an average price of $65.55, for a total value of $262,200.00. Following the sale, the vice president now directly owns 4,000 shares in the company, valued at $262,200. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, Chairman Neal L. Patterson sold 20,000 shares of the firm’s stock in a transaction on Tuesday, March 14th. The shares were sold at an average price of $54.91, for a total value of $1,098,200.00. The disclosure for this sale can be found here. Insiders have sold 593,742 shares of company stock worth $38,057,902 over the last 90 days. 13.20% of the stock is currently owned by company insiders.

Cerner Company Profile

Cerner Corporation (Cerner) is a supplier of healthcare information technology (HCIT). The Company offers a range of intelligent solutions and services that support the clinical, financial and operational needs of organizations of all sizes. The Company’s segments include Domestic and Global. The Domestic segment includes revenue contributions and expenditures associated with business activity in the United States.

12 Month Chart for NASDAQ:CERN

Receive News & Ratings for Cerner Co. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cerner Co. and related companies with's FREE daily email newsletter.

Leave a Reply